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Sp~c~tic bmdlng of ‘251-labelled GLP-I(7 36)amlde to rat lung membranes has dependent upon time and temperature and wab proportlonal to 
membrane protein concentratton Blndmg was lnhlblted in a concentration-dependent manner bq unlabelled GLP-1(7-36)amlde conslstent with 
the presence of d vnglc class of blndmg sltrs with d dlssoclatlon constant (&) of I 67 f 0 ?Y nmol.1 GLP-I( I- 36)amldc was 260 times less potent 
ln lnhlbltmg the bmdlng of *‘SI-lahelled GLP-I(7 36)amlde to lung membrwes (& of 448 & 93 nmol,l) Vasoactwe mtestlnal polqpeptlde and 
peptlde-hlstldlne-twleuclne also dlsplxed “51-labelled GLP-I(7 36)amlde from the receptor concentration-dependently; the Kd has 4 3 I i 0 X and 
7 93 i 4 79 nmol I. respcctlrely Guamne nuclrotldes (GTP-;,-S, GDP-/j-S) decreased the hlndlng of ‘Z51-lahelled GLP-I(7 36)amldc to rdt lung 
mcmhranes as uas found for GLP- l(7- 3h)amlde receptor> m RINmSF cells which were alho shown to he coupled to the adenylate cyclase system 
GLP-l17-3h)amlde. Receptor. Lung, Guamne nucleotlde, Adenqlate cyclase 
1. INTRODUCTION 2. MATERIALS AND METHODS 
Glucagon-like peptide-1(7-36)amide is a posttransla- 
tional processing product of proglucagon in the mam- 
malian intestine [l-3]. Since it is released in response 
to oral glucose loads and has been shown to be a power- 
ful stimulator of the glucose-induced insulin release 
[2,4-61, it was concluded to represent an important in- 
cretin candidate. Receptors for GLP-1(7-36)amide are 
present in different tissues. Previously, we identified 
and characterized high-affinity receptors for 
GLP-1(7-36)amide in a rat insulinoma-derived cell line 
(RINmSF) [7,8] which are coupled to the adenylate 
cyclase system [9]. Uttenthal and Blizquez 
demonstrated the presence of GLP-1(7-36)amide 
receptors on isolated rat gastric glands [lo]. Binding of 
GLP-1(7-36)amide to gastric glands resulted in an in- 
crease of CAMP suggesting that like in RINmSF cells 
the receptor for GLP-1(7-36)amide is linked to the 
adenylate cyclase. Several studies showed that in brain 
the thalamus, hypothalamus, pituitary gland and 
medulla oblongata are rich in GLP-1(7-36)amide bin- 
ding sites [l 1,121. Recently, it has been shown that 
GLP-1(7-36)amide binds specifically to rat lung mem- 
branes and that this binding is pH dependent [12]. The 
present study was performed to further characterize 
GLP-1(7-36)amide receptors on rat lung membranes. 
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7. I Reugerrts 
GLP-1(7-36)amide, GLP-I(l-36)amlde. glucagon-hke peptIde- 
(GLP-I?), oxyntomodulin. glucagon, Latoactive mte<tlnal peptide 
(VIP) and peptlde-hlstldme-lsoleuclne (PHI) \vere purchased from 
Prmnsula Laboratorle5 (St. Helens. hlerseyclde. UK). Glucagon- 
related pancreatic peptide (CRPP) wa< Llndly donated by Dr A. 
Moody (Nova Research Inbtltute, Denmark). GTP-3-S and GDP-J-S 
were from Sigma Chemicals (Detsenhoien. FRG). 
Iodination of GLP-1(7-36)amlde was carried out using a modified 
IODOGEN method [13] ac described 1n detail prebiously [7]. The 
speclflc actlwty of the label wa\ estunated to be appro\unately 
74 TBq~‘mmol 
2.3. Preparatron of rat lung membrunes 
Membrane> were prepared as described in detail prewously [S] wth 
minor modiflcatlons. Brielly. male albmo \Vistar rats (200-220 g 
body weight) were kllled by decapltatlon, the lungs were removed and 
homogenized m IO mhl trls(hqdroxymethqI)aminomethane 
hydrochloride (Trl\-HCI). 30 mhl NaCl, 1 mhl dlthlothreltol, 5 pM 
phenylmethylsulfonqltluorlde (PhlSF). pH 7.5, with an Ultra-Turrax 
followed by a further homogemratlon using a glasvglass 
homogenizer. The homogenate was layered oker a 41’% (a, v) sucrose 
solution and centrifuged for 60 mln at 4°C at 95000 x ,g. The band 
at the Interface of the layers represented the membrane5 and \\a\ col- 
lected, diluted and centrifuged for 30 mm at 4°C at 40000 \ g. The 
pellet was resuspended in a modified Krebq-Ranger buffer (KRB) 
(Trls-HCI 2.5 mhl, NaCl 120 mM, MgSOJ 1 2 mM, KCI 5 mhl, 
CHJCOONa 15 mhl; pH 7 4) containing 1% (u’!v) human serum 
albumln. 0 1% (v/v) bacltracin and EDTA I mhl, frozen in liqtnd 
nitrogen and stored at -80°C Protein concentration was determined 
as dexrlbed by Bradford [14]. 
h,Iembranes (1 mg,ml) aere Incubated with “‘l-1abelled 
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Fig. 1. (A) Specific binding of ‘“51-labelled GLP-1(7-36)amtde to 
lung membranes (I mg/ml) at 37°C (13) and 10°C (0) (means + SE, 
n = 4). (B) Specific binding of “51-labelled GLP-l(7736)amide to 
lung membranes as a function of protein concentratton (means + SE; 
n = 4). 
GLP-1(7-36)amide (approx. 40000 cpm) in modtfied KRB at 37°C 
for 30 min m the presence of the indicated substances. After cen- 
trifugatton for 5 min at 4°C at 11500 x g the pellet was counted in 
a y-counter (Hydragamma 16, Innotron, Oxford, UK). Nonspecific 
binding was defined as binding m the presence of 1 pmol/l 
GLP-1(7-36)amide and was subtracted in every case from the total- 
binding value. 
3. RESULTS 
Binding of 1251-labelled GLP-1(7-36)amide to rat 
lung membranes (1 mg/ml protein) was temperature- 
dependent. Binding was rapid at 37°C and markedly 
reduced at 10°C (Fig. 1). Binding was dependent on 
membrane protein concentration over the protein con- 
centration range of lo-lOOpg/sample (Fig. 1). 
Binding of 1251-labelled GLP-1(7-36)amide was in- 
hibited in a concentration-dependent manner by 
GLP-1(7-36)amide consistent with the presence of a 
single class of binding sites with a dissociation constant 
(&) of 1.67 f 0.29 nmol/l (Fig. 2). Binding of 1251- 
labelled GLP-1(7-36)amide was also inhibited in a 
concentration-dependent manner by 
GLP-1(7-36)amide but the binding affinity was ap- 
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Fig. 2. Inhibition of binding of ‘251-labelled GLP-1(7-36)amide to 
lung membranes by GLP-1(7-36)amide (‘8) (n = 4). (A) 
GLP-l(l-36)amide (0) (n = 4), glucagon (m) (n = 6) and GLP-2 (0) 
(n = 6). (B) VIP (0) (n = 5), PHI (0) (n = 6) and owyntomodulin 
(w) (n = 6). Data points show means + SE. 
proximately 260-fold less than that of the truncated 
peptide. The Kd was 448 -+ 93 nmol/l (Fig. 2). VIP and 
PHI were also able to displace *2SI-labelled 
GLP-1(7-36)amide concentration-dependently with a 
Kd of 4.31 f 0.8 and 7.93 + 4.79 nmol/l, respectively 
(Fig. 2). Binding of tracer was weakly, but 
reproducibly, inhibited by glucagon and GLP-2. Thus, 
at a concentration of 1 pmol/l, glucagon and GLP-2 in- 
hibited binding of tracer by 45% (Fig. 2). Binding of 
label was not significantly inhibited by oxyntomodulin 
and GRPP. 
Table I 
Effect of GDP-p-S and GTP-y-S on binding of ‘z51-labelled 
GLP-1(7-36)amtde to rat lung membranes (means f SE; n = 6) 
0. I pmol/l 1 .O pmol/l 10 pmol/l 100 pmol/l 
- 
Control 100 
GDP-P-S 62.0 k 1.73 24.17 k 0.83 11.33 k 0.88 9.0 t 0.58 
GTP-7-S 64.83 f 5.30 15.33 f 1.12 11.50 f 0.34 
Binding is expressed as % of tracer max. specifically bound per 
100 pg membrane protem 
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In further experiments lung membranes (1 mg/ml 
protein) were incubated for 30 min at 37°C with lz51- 
labelled GLP-1(7-36)amide in the absence or presence 
of a range of concentrations of GTP-T-S and GDP-P-S. 
As shown in Table I, binding of tracer was inhibited in 
a concentration-dependent manner by the nucleotides. 
4. DISCUSSION 
Our results demonstrate the presence of high affinity 
receptors for GLP-1(7-36)amide on isolated rat lung 
membranes. Consistent with the data of Kanse et al. 
[12], we found that GLP-1(1-36)amide competes with 
‘251-labelled GLP-1(7-36)amide much less strongly 
than GLP-1(7-36)amide. In contrast to their results, 
we found that VIP and PHI were more potent in 
displacing ‘251-labelled GLP-1(7-36)amide than other 
proglucagon-derived peptides, except GLP- 
1(7-36)amide itself. The order of potency was 
GLP-1(7-36)amide > VIP > PHI > 
GLP-1(1-36)amide > glucagon and GLP-2. 
Previously we identified and characterized receptors 
for GLP-1(7-36)amide on rat insulinoma-derived 
RINmSF cells [7,8]. Our results show that the binding 
affinity of GLP-1(7-36)amide on rat lung receptors is 
10 times less compared to the receptors on RINm5F 
cells (1.67 + 0.29 nmol/l vs 0.204 k 0.08 nmol/l). 
While VIP and PHI did not bind to GLP-1(7-36)amide 
receptors on insulinoma cells both peptides were able to 
displace “I-labelled GLP-1(7-36)amide with a Kd 
which was 2.5 and 4.7 times, respectively, less than that 
of GLP-1(7-36)amide. 
Previously, we demonstrated that GLP- 
1(7-36)amide receptors on RINm5F cells are 
coupled to the adenylate cyclase system [9]. We now 
show that binding of “’ I-labelled GLP-1(7-36)amide 
to lung membranes is decreased in the presence of 
guanine nucleotides suggesting that these receptors are 
also linked to adenylate cyclase system. 
The presence of GLP-1(7-36)amide receptors on rat 
lung membranes indicates that the peptide may not on- 
ly act, as has been suggested, as an incretin [2,4-61 but 
ma; have additional, so far undefined, functions. 
Studies are currently underway to obtain information 
on the possible functional relevance of these findings. 
Interestingly, there are several reports of the presence 
of GLP-1(7-36)amide binding sites in the brainstem 
[I 1,15-191. These findings along with ours infer that 
GLP-1(7-36)amide may have a role in peripheral and 
central regulation of pulmonary function. 
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